Diominic-DCA Tablet

• Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them Common side effects of Diominic Dca Headache Tachycardia Palpitations Dizziness Fear Restlessness Anxiety Tremors Insomnia (difficulty in sleeping) Nausea Weakness Discomfort when urinating Hallucination Convulsion

If you experience any persistent or severe side effects, consult your doctor immediately.

• Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Diominic Dca Tablet may be taken with or without food, but it is better to take it at a fixed time.

• How Diominic Dca Tablet works Diominic Dca Tablet is a combination of four medicines: Caffeine, Chlorpheniramine Maleate, Paracetamol, and Phenylephrine, which relieves common cold symptoms.

• 
  Alcohol:

  It is unsafe to consume alcohol with Diominic Dca Tablet.

• 
  Driving:

  Diominic Dca Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

• 
  Kidney:

  Diominic Dca Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Diominic Dca Tablet may not be needed in these patients. Please consult your doctor. Use of Diominic Dca Tablet may cause excessive sleepiness in patients with end stage kidney disease.

• 
  Liver:

  Diominic Dca Tablet should be used with caution in patients with liver disease. Dose adjustment of Diominic Dca Tablet may be needed. Please consult your doctor.

• 
  Pregnancy:

  Diominic Dca Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

• 
  Breastfeeding:

  Diominic Dca Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.